A retrospective multicentric study on the effectiveness of intravenous brivaracetam in seizure clusters: Data from the Italian experience. Niccolò Orlandi , Giuseppe d'Orsi , Giada Pauletto , Annacarmen Nilo , Luigi Sicurella , Francesca Pescini , Francesca Giglia , Angelo Labate , Angelina Laganà , Rosaria Renna , Salvatore Maria Cavalli , Leila Zummo , Mario Coletti Moja , Catello Vollono , Annarita Sabetta , Federica Ranzato , Salvatore Zappulla , Daniela Audenino , Stefania Miniello , Peiman Nazerian , Daniela Marino , Simona Lattanzi , Marta Piccioli , Anna Estraneo , Andrea Zini , Serena Servo , Giada Giovannini , Stefano Meletti , Daria Bianchini , Sara Contardi , Alessandra Fasolino , Giulio Maria Fiore , Nicoletta Foschi , Antonello Giordano , Patrizia Laisa , Daniele Lo Coco , Simona Maccora , Adriana Magaudda , Mariangela Panebianco , Elena Merli , Giovanni Piccirillo , Matteo Pugnaghi , Lorenzo Ramacciotti , Anna Elisabetta Vaudano , Giuseppina Vitale , Anna Zaniboni Seizure（2023）
摘要
In our cohort, IV BRV resulted to be well tolerated for the treatment of SC and it could be considered as a treatment option, particularly in case of in-hospital onset. However, the underlying etiology seems to be the main outcome predictor.
更多 查看译文
关键词
Brivaracetam, Efficacy, Seizure cluster, Treatment
AI 理解论文
溯源树
样例
